Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eric Vicaut

Showing results (461-470 of 522) with videos related to

Pageof 53
Sort By:
European Journal of Heart Failure|October 10, 2021
Early and short-term intensive management after discharge for patients hospitalized with acute heart failure: a randomized study (ECAD-HF)Damien Logeart, Emmannuelle Berthelot, Nicolas Bihry, et al.
The New England Journal of Medicine|March 15, 2013
Family presence during cardiopulmonary resuscitationPatricia Jabre, Vanessa Belpomme, Elie Azoulay, et al.
European Journal of Heart Failure|April 11, 2017
Effect of intracoronary administration of AAV1/SERCA2a on ventricular remodelling in patients with advanced systolic heart failure: results from the AGENT-HF randomized phase 2 trialJean-Sébastien Hulot, Joe-Elie Salem, Alban Redheuil, et al.
American Heart Journal|February 9, 2018
Duration of ischemia and treatment effects of pre- versus in-hospital ticagrelor in patients with ST-segment elevation myocardial infarction: Insights from the ATLANTIC studyAkshay Bagai, Shaun G Goodman, Warren J Cantor, et al.
European Heart Journal|August 30, 2025
Aspirin dosing after acute coronary syndrome with suspected aspirin resistance: the ANDAMAN trialJean-Guillaume Dillinger, Théo Pezel, Laure Batias, et al.
European Heart Journal|September 14, 2015
Stopping or continuing clopidogrel 12 months after drug-eluting stent placement: the OPTIDUAL randomized trialGérard Helft, Philippe Gabriel Steg, Claude Le Feuvre, et al.
European Heart Journal|May 18, 2022
Apixaban vs. standard of care after transcatheter aortic valve implantation: the ATLANTIS trialJean Philippe Collet, Eric Van Belle, Holger Thiele, et al.
Lancet (London, England)|November 26, 2013
Medical management with or without interventional therapy for unruptured brain arteriovenous malformations (ARUBA): a multicentre, non-blinded, randomised trialJ P Mohr, Michael K Parides, Christian Stapf, et al.
Therapie|February 4, 2018
Jean-François Dhainaut, Laure Huot, Valérie Bouchara Pomar, et al.
American Heart Journal|April 23, 2025
Twice-a-day administration of aspirin in patients with diabetes mellitus or aspirin resistance after acute coronary syndrome: Rationale and design of the randomized ANDAMAN trialJean-Guillaume Dillinger, Théo Pezel, Laure Batias, et al.
Pageof 53

Showing results (461-470 of 522) with videos related to

Sort By:
Pageof 53
European Journal of Heart Failure|October 10, 2021
Early and short-term intensive management after discharge for patients hospitalized with acute heart failure: a randomized study (ECAD-HF)Damien Logeart, Emmannuelle Berthelot, Nicolas Bihry, et al.
The New England Journal of Medicine|March 15, 2013
Family presence during cardiopulmonary resuscitationPatricia Jabre, Vanessa Belpomme, Elie Azoulay, et al.
European Journal of Heart Failure|April 11, 2017
Effect of intracoronary administration of AAV1/SERCA2a on ventricular remodelling in patients with advanced systolic heart failure: results from the AGENT-HF randomized phase 2 trialJean-Sébastien Hulot, Joe-Elie Salem, Alban Redheuil, et al.
American Heart Journal|February 9, 2018
Duration of ischemia and treatment effects of pre- versus in-hospital ticagrelor in patients with ST-segment elevation myocardial infarction: Insights from the ATLANTIC studyAkshay Bagai, Shaun G Goodman, Warren J Cantor, et al.
European Heart Journal|August 30, 2025
Aspirin dosing after acute coronary syndrome with suspected aspirin resistance: the ANDAMAN trialJean-Guillaume Dillinger, Théo Pezel, Laure Batias, et al.
European Heart Journal|September 14, 2015
Stopping or continuing clopidogrel 12 months after drug-eluting stent placement: the OPTIDUAL randomized trialGérard Helft, Philippe Gabriel Steg, Claude Le Feuvre, et al.
European Heart Journal|May 18, 2022
Apixaban vs. standard of care after transcatheter aortic valve implantation: the ATLANTIS trialJean Philippe Collet, Eric Van Belle, Holger Thiele, et al.
Lancet (London, England)|November 26, 2013
Medical management with or without interventional therapy for unruptured brain arteriovenous malformations (ARUBA): a multicentre, non-blinded, randomised trialJ P Mohr, Michael K Parides, Christian Stapf, et al.
Therapie|February 4, 2018
Jean-François Dhainaut, Laure Huot, Valérie Bouchara Pomar, et al.
American Heart Journal|April 23, 2025
Twice-a-day administration of aspirin in patients with diabetes mellitus or aspirin resistance after acute coronary syndrome: Rationale and design of the randomized ANDAMAN trialJean-Guillaume Dillinger, Théo Pezel, Laure Batias, et al.
Pageof 53